Kerrigan, D P <br/><br/>
Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administration.  [electronic resource] 

 -  American journal of clinical pathology  Sep 1989 
 - 280-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0002-9173 
<br/><br/><label>Standard No.: </label>10.1093/ajcp/92.3.280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Blood Cells--pathology<br/>Bone Marrow--pathology<br/>Cell Survival<br/>Cisplatin--administration & dosage<br/>Colony-Stimulating Factors--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor<br/>Granulocytes--pathology<br/>Humans<br/>Lymphocytes--pathology<br/>Male<br/>Middle Aged<br/>Monocytes--pathology<br/>Recombinant Proteins